Meg Jardine

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +17

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E. de Galan et al. · Journal of the American Society of Nephrology · 2009 · 973 citations · Full text

Medicine, Endocrinology, Nephrology +17

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

Jicheng Lv, Hong Zhang, Muh Geot Wong et al. · JAMA · 2017 · 530 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Catherine M. Clase, Juan Jesús Carrero, David H. Ellison et al. · Kidney International · 2019 · 477 citations · Full text

Medicine, Nephrology, Nutrition +17

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects

Hiddo J.L. Heerspink, Mehul Desai, Meg Jardine et al. · Journal of the American Society of Nephrology · 2016 · 348 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17